Tango Therapeutics, Inc. (TNGX) Financials
Key financial figures for Tango Therapeutics, Inc. (Q1 2026).
- Revenue
- $0
- Net Income
- -$46M
- EPS
- $-0.32
- Total Assets
- $436M
- Operating Cash Flow
- -$44M
Full income statement, balance sheet, and cash flow for Tango Therapeutics, Inc. on SentiSense.